Stocksigma LogoStocksigma Logo

Genesys International: CARE Monitoring Report Highlights QIP Deviations and Utilization Timeline Delays

CARE Ratings' monitoring report for the quarter ended 30th Sep'26 highlighted deviations in Genesys International's ₹110.00 crore QIP proceeds

Genesys International: CARE Monitoring Report Highlights QIP Deviations and Utilization Timeline Delays

Genesys International Corporation Ltd · Others (Uncategorized) · 14 Nov 2026, 2:33 am

Genesys International: CARE Monitoring Report Highlights QIP Deviations and Utilization Timeline Delays CARE Ratings' monitoring report for the quarter ended 30th Sep'26 highlighted deviations in Genesys International's ₹110.00 crore QIP proceeds. An amount of ₹6.60 crore was temporarily diverted to non-specified purposes via current account transfers before being returned on 3rd Sep'26. Additionally, utilization of ₹75.29 crore faces delays, extending the timeline from 31st Mar'26 to 31st Mar'27. Total QIP deployment reached ₹46.62 crore, with ₹63.38 crore unutilized. Meanwhile, proceeds from its ₹125.37 crore Rights Issue saw ₹41.72 crore utilized with zero deviations reported.

Original exchange filing (PDF)

More announcements from Genesys International Corporation Ltd

All Genesys International Corporation Ltd announcements